The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
CAR-T Meeting 2024 | An update on the experience with CAR T-cell therapy in China
In this video, He Huang, MD, PhD, Zhejiang University School of Medicine, Zhejiang, China, provides an update on the experience with CAR T-cell therapy in China. Prof. Huang highlights that the number of clinical trials and the use of CAR-T in clinical practice is increasing, and he hopes that collaboration with European countries will further enhance the CAR-T field in China. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
